Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)
China flag China · Delayed Price · Currency is CNY
29.56
-0.16 (-0.54%)
Nov 19, 2024, 9:49 AM CST

Hubei Jumpcan Pharmaceutical Revenue

Hubei Jumpcan Pharmaceutical had revenue of 1.77B CNY in the quarter ending September 30, 2024, a decrease of -7.18%. This brings the company's revenue in the last twelve months to 8.92B, down -7.43% year-over-year. In the year 2023, Hubei Jumpcan Pharmaceutical had annual revenue of 9.65B with 7.32% growth.

Revenue (ttm)
8.92B
Revenue Growth
-7.43%
P/S Ratio
3.08
Revenue / Employee
1.71M
Employees
5,230
Market Cap
27.54B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.65B658.17M7.32%
Dec 31, 20229.00B1.37B17.90%
Dec 31, 20217.63B1.47B23.77%
Dec 31, 20206.16B-775.02M-11.17%
Dec 31, 20196.94B-268.21M-3.72%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition